Results 101 to 110 of about 1,072 (154)

Early multi-cancer detection using liquid biopsy: emerging biomarkers and clinical strategies. [PDF]

Front Oncol
Nirob SR, Morol MK, Rahman D, Hui LT, Nandi D, Rahman M, Al Jubair A.   +6 more
europepmc   +1 more source

From concept to clinic: emerging paradigms and novel insights into liquid biopsy. [PDF]

Cancer Biol Med
Guo W, Liu Y, Dong H, Li X, Guo X, Guo H, Zhou K, Xing J.   +7 more
europepmc   +1 more source

Emerging Role of ctDNA Fragmentomics and Epigenetic Signatures in the Early Detection, Minimal Residual Disease Assessment, and Precision Monitoring of Renal Cell Carcinoma. [PDF]

J Cell Mol Med
Kamli H, Khan NU.
europepmc   +1 more source

Circulating Cell-free DNA as a biomarker for radiation-induced injury: From mechanistic insights to clinical translation. [PDF]

Cancer Metastasis Rev
Sun Q, Li Y, Yin T, Teng F, Yu J.
europepmc   +1 more source

A machine learning framework combining cfDNA fragmentomics and serum biomarkers for early ovarian cancer detection. [PDF]

Cell Commun Signal
Weng W, Rao Q, Wang S, Lei R, Li R, Lin L, Liu Y, Zhu D, Bao H, Zhang W, Wei J, Qing X, Ruan X, Xu G, Zhang B.   +14 more
europepmc   +1 more source

Characterization of global cfDNA fragmentomics in Melanoma Patients

EJC Skin Cancer
J.L. Villanueva-Cañas, D. Rizo-Potau, A. Fornies, M. Aguilar, C. Sanchez-Cardenas, C. Carrera, S. Puig, J. Malvehy, J.A. Puig-Butille   +8 more
openaire   +1 more source

Circulating cell-free mtDNA fragmentomics for early detection of gastric cancer and precancerous lesions. [PDF]

Cell Rep Med
Dang M, Wang S, Zhang H, Xu H, Lu L, Liu Y, Jiao H, Yang W, Peng F, Gao X, Lin F, Dong K, Pan K, Li W, Lu R, Nie Y, Liu Y, Xing J.   +17 more
europepmc   +1 more source

Liquid biopsy, multi-cancer early detection, and artificial intelligence: new frontiers in cancer screening from a technological and immunological perspective. [PDF]

Front Immunol
Wu D, Yu Q, Wu Q, Wang X, Wei H, Li F, Li G, Wang X, Wang X.   +8 more
europepmc   +1 more source

Holistic determination of ends of cfDNA molecules. [PDF]

Cell Genom
Jiang P, Ma ML, Qiao R, Shi Y, Liu J, Zhou Q, Peng W, Lam WKJ, Bai J, Choy LYL, Tsui WHA, Malki Y, Kang G, Yu SCY, Xiong D, Wong GLH, Chan LL, Wong J, Chan SL, Wong VWS, Chan KCA, Lo YMD.   +21 more
europepmc   +1 more source

Cell-free DNA fragmentomics as a non-invasive tool for predicting pathologic response in colorectal cancer. [PDF]

Am J Clin Exp Immunol
Hu W, Li G, Dong W, Lu Y, Li Z, Zheng Q.
europepmc   +1 more source